Effect of cyclosporine on reperfusion injury in acute myocardial infarction.
about
Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trialInhibition of the Mitochondrial Permeability Transition for Cytoprotection: Direct versus Indirect MechanismsESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapiesTranslocator protein (18 kDa): a promising therapeutic target and diagnostic tool for cardiovascular diseasesNo reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotectionStrategies for Pharmacological Organoprotection during Extracorporeal Circulation Targeting Ischemia-Reperfusion InjuryReducing myocardial infarct size: challenges and future opportunitiesMyocardial Dysfunction and Shock after Cardiac ArrestMitochondrial dynamics in cardiovascular health and diseaseStenting technique, gender, and age are associated with cardioprotection by ischaemic postconditioning in primary coronary intervention: a systematic review of 10 randomized trialsRole of the MPTP in conditioning the heart - translatability and mechanismIschaemic postconditioning: cardiac protection after the eventProgrammed necrosis in acute kidney injuryMyocardial reperfusion injury: looking beyond primary PCICardioprotection: a review of current practice in global ischemia and future translational perspectiveFrom ATP to PTP and Back: A Dual Function for the Mitochondrial ATP SynthaseAttenuating myocardial ischemia by targeting A2B adenosine receptorsPostconditioning signalling in the heart: mechanisms and translatabilityTargeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of CardiologyThe pathobiology of acute coronary syndromes: clinical implications and central role of the mitochondriaMyocardial protection with mild hypothermiaXenotransplantation of Human Cardiomyocyte Progenitor Cells Does Not Improve Cardiac Function in a Porcine Model of Chronic Ischemic Heart Failure. Results from a Randomized, Blinded, Placebo Controlled TrialNanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-AIschaemic conditioning and targeting reperfusion injury: a 30 year voyage of discoveryTargeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic NephropathyThe mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotectionEndonuclease G mediates α-synuclein cytotoxicity during Parkinson's diseasePotent cardioprotective effect of the 4-anilinoquinazoline derivative PD153035: involvement of mitochondrial K(ATP) channel activationRyanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusionAttenuation of skeletal muscle and renal injury to the lower limb following ischemia-reperfusion using mPTP inhibitor NIM-811The compound Chinese medicine "Kang Fu Ling" protects against high power microwave-induced myocardial injuryMitochondrial targeting of cyclosporin A enables selective inhibition of cyclophilin-D and enhanced cytoprotection after glucose and oxygen deprivationCaMKII determines mitochondrial stress responses in heartPhosphate is essential for inhibition of the mitochondrial permeability transition pore by cyclosporin A and by cyclophilin D ablationSilencing of cardiac mitochondrial NHE1 prevents mitochondrial permeability transition pore opening.Targeting of adenosine receptors in ischemia-reperfusion injury.In vivo quantification of VCAM-1 expression in renal ischemia reperfusion injury using non-invasive magnetic resonance molecular imaging.Nonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon.
P2860
Q21245483-31ECA74C-057E-4E96-8610-8981065A19E8Q21296696-C62EF4EF-88D5-431F-A321-9980D86DFF6EQ24289195-D86BA59A-C817-4B3E-AAFE-1A2AAB146348Q24602947-E7A7707C-A3AD-423A-9440-B67E6A758407Q26740252-4EC14FBC-7B81-4FBD-92E6-D41BF0938CA2Q26750797-4C392978-271E-4122-A0B1-5C5DA772FEA3Q26770727-C36D1D57-5063-4200-8EDD-035AC8206028Q26775395-F9C54938-CA17-4085-95E9-565968B1BDB7Q26784080-FC8BF96A-D9AF-4EE6-9062-617C90DCB0BDQ26820835-2F8190A0-1EB7-433C-B122-7C398F97D9A7Q26825240-059D50A3-CDCF-407F-99F4-300A203F4F1CQ26830560-90410439-35D3-4334-840B-2F5D13123E84Q26853129-824F1488-F7E9-48B0-BD11-27E1201D7750Q26865577-781B9BE9-16C2-4103-B069-4EB105B87E2DQ26991482-30A8CADB-A0CA-48A0-93AD-DF7E3546265DQ26996274-ADB10D2B-AD8B-460F-A98C-DC39208DADF6Q27004110-9F48808B-A4FE-45E8-A446-BCF2354B5DE4Q27006863-3B1ED3D9-BA7D-4C7E-9D96-B648D6DD7B93Q27021021-FC7E5B11-52CD-4B95-BCA8-910F1C6F3D6FQ27024879-57907072-C1D5-4F9B-880B-8A4FF6C71B10Q27026299-4B881740-4D39-4779-AAF0-2CEFB160DBCFQ27027205-14CE7817-FCA4-48DE-AF7C-8448438F8A22Q27336487-9FA12DBA-2D13-4ED1-957D-3653FBD7901DQ27350484-AFF7D7EB-27CB-4D71-BA31-247C1B52425CQ27437615-6898C769-9CA6-4442-9D32-C4A7EBA5941EQ28072918-C2AC604A-4870-4FF9-AB86-E90759D9D965Q28083205-EFEC0616-2E6E-48B9-918A-3768105013D6Q28248925-78B2A942-E586-4A75-B80B-8F633E4FE984Q28300290-3F5A563B-B1FD-4405-AEC1-F9CE0045FD3AQ28473949-9BE387F7-CB47-4A70-A3A9-3DAE82AAE159Q28508488-0548B3C9-D4ED-4149-BF06-CF20AC1BC8DCQ28540094-65F80C3F-E6DB-49D5-92B6-329B171D37FDQ28540340-EB438878-DECB-46D5-8A5B-AEE7ABF46BFFQ28579857-8495D48B-261E-40AB-88CD-729694E13E09Q28591986-F62967CE-473A-4C72-9DCD-693E1BFE9640Q28594159-398795EC-B222-4469-8B36-ECBBF1FF3FC4Q29346988-A306A2D8-B151-4029-B7B8-3D242CCE76EEQ30429069-88FCC7E2-0288-412B-B979-634E027B8167Q30479461-6F1EDF8A-67F6-4B47-8423-8A5A7B76AFA6Q30583012-3580AE34-7069-433D-B2F3-906A2E10FC5E
P2860
Effect of cyclosporine on reperfusion injury in acute myocardial infarction.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Effect of cyclosporine on reperfusion injury in acute myocardial infarction.
@en
Effect of cyclosporine on reperfusion injury in acute myocardial infarction.
@nl
type
label
Effect of cyclosporine on reperfusion injury in acute myocardial infarction.
@en
Effect of cyclosporine on reperfusion injury in acute myocardial infarction.
@nl
prefLabel
Effect of cyclosporine on reperfusion injury in acute myocardial infarction.
@en
Effect of cyclosporine on reperfusion injury in acute myocardial infarction.
@nl
P2093
P50
P356
P1476
Effect of cyclosporine on reperfusion injury in acute myocardial infarction.
@en
P2093
Catherine Sportouch
Christophe Macia
Didier Revel
Eric Bonnefoy
Franck Raczka
Gerald Gahide
Gilbert Kirkorian
Gilles Rioufol
Gérard Finet
Hélène Thibault
P304
P356
10.1056/NEJMOA071142
P407
P577
2008-07-01T00:00:00Z